1. Home
  2. JFU vs CTSO Comparison

JFU vs CTSO Comparison

Compare JFU & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 9F Inc.

JFU

9F Inc.

HOLD

Current Price

$3.08

Market Cap

46.7M

Sector

Finance

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.49

Market Cap

39.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JFU
CTSO
Founded
2006
1997
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.7M
39.5M
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
JFU
CTSO
Price
$3.08
$0.49
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.38
AVG Volume (30 Days)
7.2K
98.6K
Earning Date
12-09-2022
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.79
EPS
N/A
N/A
Revenue
N/A
$22,503,908.00
Revenue This Year
N/A
$10.34
Revenue Next Year
N/A
$22.41
P/E Ratio
$1.43
N/A
Revenue Growth
N/A
48.53
52 Week Low
$1.25
$0.44
52 Week High
$9.48
$1.39

Technical Indicators

Market Signals
Indicator
JFU
CTSO
Relative Strength Index (RSI) 41.97 38.56
Support Level $2.65 $0.44
Resistance Level $4.79 $0.74
Average True Range (ATR) 0.47 0.05
MACD -0.07 -0.00
Stochastic Oscillator 7.07 28.21

Price Performance

Historical Comparison
JFU
CTSO

About JFU 9F Inc.

9F Inc is a digital technology and wealth management service provider aiming to empower institutional partners with financial technologies as well as attract investors with investment opportunities that come with the vast potential of China's new consumer economy and the appreciation of world-wide assets and access to quality products at a competitive price. The Company's operations are organized into segments, consisting of E-commerce services, technology Empowerment service, and Wealth Management services.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: